Pnc Financial Services Group, Inc. Pmv Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 71,006 shares of PMVP stock, worth $97,988. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,006
Previous 60,820
16.75%
Holding current value
$97,988
Previous $64,000
54.69%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PMVP
# of Institutions
71Shares Held
40.4MCall Options Held
100Put Options Held
0-
Orbimed Advisors LLC San Diego, CA5.98MShares$8.25 Million0.29% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.29MShares$7.3 Million6.78% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$6.6 Million0.3% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.3MShares$4.56 Million0.1% of portfolio
-
Sio Capital Management, LLC New York, NY2.64MShares$3.64 Million1.28% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $63M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...